Buckingham Research’s Richard Safran upgraded the rating for Boeing Co (NYSE: BA) from Underperform to Neutral, while reducing the price target from $108 to $102. He cited the absence of near-term negative catalysts as the reason for the upgrade.
There already seems to be significant negative sentiment on account of the threat of an SEC investigation into Boeing’s program accounting. Since the company’s program accounting is complex, an SEC probe could take some time to complete. The potential risks from an SEC probe “are well understood,” analyst Richard Safran said, while adding that it could remain an overhang on shares.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Safran believes the consensus expectations are optimistic, reflecting a 10 percent FCF yield in 2016, 12 percent in 2017 and even higher after that. He expects Boeing to miss expectations after 2016 due to lower-than-anticipated production rates and a larger-than-expected impact from new development programs on the company’s working capital.
The EPS estimate for 2016 has been reduced from $9.00 to $8.52. The price target reduction reflects a shift in valuation to 2017E, which is at $9.30. “Our lower price target and valuation multiple reflects the additional downside risk to our FCF and EPS estimates,” the analyst wrote.